Nektar Therapeutics Statistics
Total Valuation
NKTR has a market cap or net worth of $1.33 billion. The enterprise value is $1.20 billion.
Important Dates
The next estimated earnings date is Wednesday, March 11, 2026, after market close.
| Earnings Date | Mar 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NKTR has 20.34 million shares outstanding. The number of shares has increased by 14.07% in one year.
| Current Share Class | 20.34M |
| Shares Outstanding | 20.34M |
| Shares Change (YoY) | +14.07% |
| Shares Change (QoQ) | +34.49% |
| Owned by Insiders (%) | 0.88% |
| Owned by Institutions (%) | 68.82% |
| Float | 18.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.67 |
| Forward PS | 30.63 |
| PB Ratio | 12.93 |
| P/TBV Ratio | 15.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 19.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.24, with a Debt / Equity ratio of 1.96.
| Current Ratio | 4.24 |
| Quick Ratio | 4.09 |
| Debt / Equity | 1.96 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.13 |
Financial Efficiency
Return on equity (ROE) is -180.24% and return on invested capital (ROIC) is -450.92%.
| Return on Equity (ROE) | -180.24% |
| Return on Assets (ROA) | -27.97% |
| Return on Invested Capital (ROIC) | -450.92% |
| Return on Capital Employed (ROCE) | -58.03% |
| Weighted Average Cost of Capital (WACC) | 11.70% |
| Revenue Per Employee | $1.03M |
| Profits Per Employee | -$1.98M |
| Employee Count | 61 |
| Asset Turnover | 0.21 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -428,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +509.52% in the last 52 weeks. The beta is 1.34, so NKTR's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | +509.52% |
| 50-Day Moving Average | 44.47 |
| 200-Day Moving Average | 36.72 |
| Relative Strength Index (RSI) | 78.48 |
| Average Volume (20 Days) | 1,158,362 |
Short Selling Information
The latest short interest is 3.26 million, so 16.04% of the outstanding shares have been sold short.
| Short Interest | 3.26M |
| Short Previous Month | 2.94M |
| Short % of Shares Out | 16.04% |
| Short % of Float | 17.28% |
| Short Ratio (days to cover) | 3.24 |
Income Statement
In the last 12 months, NKTR had revenue of $62.60 million and -$120.74 million in losses. Loss per share was -$7.90.
| Revenue | 62.60M |
| Gross Profit | 54.62M |
| Operating Income | -136.36M |
| Pretax Income | -121.16M |
| Net Income | -120.74M |
| EBITDA | -135.20M |
| EBIT | -136.36M |
| Loss Per Share | -$7.90 |
Full Income StatementBalance Sheet
The company has $270.21 million in cash and $167.08 million in debt, with a net cash position of $103.13 million or $5.07 per share.
| Cash & Cash Equivalents | 270.21M |
| Total Debt | 167.08M |
| Net Cash | 103.13M |
| Net Cash Per Share | $5.07 |
| Equity (Book Value) | 85.09M |
| Book Value Per Share | 4.33 |
| Working Capital | 215.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$189.74 million and capital expenditures -$612,000, giving a free cash flow of -$190.35 million.
| Operating Cash Flow | -189.74M |
| Capital Expenditures | -612,000 |
| Free Cash Flow | -190.35M |
| FCF Per Share | -$9.36 |
Full Cash Flow StatementMargins
Gross margin is 87.26%, with operating and profit margins of -217.83% and -192.87%.
| Gross Margin | 87.26% |
| Operating Margin | -217.83% |
| Pretax Margin | -193.55% |
| Profit Margin | -192.87% |
| EBITDA Margin | -215.97% |
| EBIT Margin | -217.83% |
| FCF Margin | n/a |
Dividends & Yields
NKTR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.07% |
| Shareholder Yield | -14.07% |
| Earnings Yield | -9.29% |
| FCF Yield | -14.65% |
Analyst Forecast
The average price target for NKTR is $122.33, which is 87.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $122.33 |
| Price Target Difference | 87.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 20.16% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
NKTR has an Altman Z-Score of -16.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -16.94 |
| Piotroski F-Score | 3 |
